Recently, studies have proposed and confirmed that natural polyphenol compounds such as insulin sensitizers and adjuvant therapy drugs, can improve glycemic control in insulin-treated T1D-like rats (Yonamine et al., 2016). The gene discussed is INS; the disease is type 1 diabetes mellitus.